Literature DB >> 9751090

Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs.

H K Genant1, Y Jiang, C Peterfy, Y Lu, J Redei, P J Countryman.   

Abstract

OBJECTIVE: The results of different readers' interpretations of laser-digitized hand radiographs versus original radiographs were compared to determine the reproducibility of scoring of erosions (ERO), joint space narrowing (JSN), and their combination (ERO + JSN) in patients with rheumatoid arthritis (RA).
METHODS: Standardized radiographs of both hands were obtained at 2 visits (baseline and 6-24-month followup) from 30 patients with established RA. Conventional and laser-digitized (pixel sizes 50 microm and 100 microm) radiographs were scored independently by 3 experienced and trained radiologists who were blinded to the order of the visits. Scoring of radiographs was based on the validated Genant grading system.
RESULTS: Intertechnique (intrareader) correlation coefficients at baseline were 0.90-0.93 for scoring of ERO, 0.90-0.94 for scoring of JSN, and 0.92-0.95 for ERO + JSN; for scoring of progression between baseline and followup, these values were 0.93-0.97, 0.87-0.95, and 0.93-0.97, respectively. Interreader (intratechnique) correlation coefficients at baseline were 0.82-0.96 for scoring of ERO, 0.69-0.91 for scoring of JSN, and 0.80-0.95 for ERO + JSN; for scoring of progression between baseline and followup, these values were 0.90-0.97, 0.80-0.92, and 0.90-0.95, respectively. Intrareader (intratechnique) correlation coefficients were 0.90-0.97 for scoring of the original radiographs and 0.90-0.98 for scoring of the digitized images at 100 microm.
CONCLUSION: Using this modified grading system, scoring of RA progression directly from paired, high-resolution monitors of laser-digitized images of the hands provided highly reproducible results, comparable to those obtained from the original radiographs. Thus, this method may have useful applications in clinical trials involving RA.

Entities:  

Mesh:

Year:  1998        PMID: 9751090     DOI: 10.1002/1529-0131(199809)41:9<1583::AID-ART8>3.0.CO;2-H

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  35 in total

Review 1.  Interpreting radiographic data in rheumatoid arthritis.

Authors:  P A Ory
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 2.  Imaging of the hand and wrist in RA.

Authors:  B Taouli; A Guermazi; K E Sack; H K Genant
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 3.  An overview of commonly used radiographic scoring methods in rheumatoid arthritis clinical trials.

Authors:  Vinod Ravindran; Satish Rachapalli
Journal:  Clin Rheumatol       Date:  2010-08-21       Impact factor: 2.980

4.  Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger.

Authors:  Tamotsu Kamishima; Kazuhide Tanimura; Masato Shimizu; Megumi Matsuhashi; Jun Fukae; Yujiro Kon; Hiromi Hagiwara; Akihiro Narita; Yuko Aoki; Naoki Kosaka; Tatsuya Atsumi; Hiroki Shirato; Satoshi Terae
Journal:  Skeletal Radiol       Date:  2010-11-14       Impact factor: 2.199

5.  [Computer assisted radiological diagnostics of arthritic joint alterations].

Authors:  F Kainberger; G Langs; P Peloschek; T Schlager; C Schüller-Weidekamm; A Valentinitsch
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 6.  Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis.

Authors:  Gabriel Baron; Isabelle Boutron; Bruno Giraudeau; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2006-12-11       Impact factor: 19.103

Review 7.  Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis?

Authors:  Louise C Pollard
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Tocilizumab: a novel humanized anti-interleukin 6 receptor antibody for the treatment of patients with rheumatoid arthritis.

Authors:  Rieke Alten
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-06       Impact factor: 5.346

Review 9.  Biological agents for rheumatoid arthritis: targeting both physical function and structural damage.

Authors:  Alice Klinkhoff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors.

Authors:  R Westhovens; M Robles; A C Ximenes; S Nayiager; J Wollenhaupt; P Durez; J Gomez-Reino; W Grassi; B Haraoui; W Shergy; S-H Park; H Genant; C Peterfy; J-C Becker; A Covucci; R Helfrick; J Bathon
Journal:  Ann Rheum Dis       Date:  2009-01-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.